Subscribe to RSS
DOI: 10.1055/s-2007-965150
© Hippokrates Verlag in MVS Medizinverlage Stuttgart GmbH & Co. KG
Omega-3-Fettsäuren und Atherosklerose
Publication History
Publication Date:
03 April 2007 (online)
![](https://www.thieme-connect.de/media/OM/200701/lookinside/thumbnails/10.1055-s-2007-965150-1.jpg)
Zusammenfassung
Die beiden maritimen Omega-3-Fettsäuren Eicosapentaensäure (EPA) und Docosahexaensäure (DHA), nicht aber die pflanzliche Omega-3-Fettsäure α-Linolensäure, werden von kardiologischen Fachgesellschaften zur Prävention kardiovaskulärer Erkrankungen und des plötzlichen Herztodes empfohlen. Dies beruht auf einer konsistenten wissenschaftlichen Datenlage u. a. auf dem Boden von Epidemiologie, Wirkmechanismen und Ergebnissen klinischer Studien. Als Quellen für EPA und DHA kommen fetter Fisch, besser aber hochgereinigte Fischöle infrage. Zur Abschätzung des Risikos für den plötzlichen Herztod eignet sich der Omega-3-Index, der auch zur Kontrolle der Behandlung mit EPA und DHA eingesetzt werden kann.
Key words
Fisch - Fischöl - Omega-3-Fettsäuren - Ernährung - Herzinfarkt - plötzlicher Herztod
Literatur
- 1 Albert C M, Campos H, Stampfer M J, Ridker P M, Manson J E, Willett W C, Ma J. Blood levels of long-chain n-3 fatty acids and the risk of sudden cardiac death. N Engl J Med. 2002; 346 1113-8
- 2 Burr M L, Fehily A M, Gilbert J F. et al . Effects of changes in fat, fish, and fibre intakes on death and myocardial infarction: diet and reinfarction trial (DART). Lancet. 1989; 2 757-61
- 3 Burr M L, Ashfield-Watt P AL, Dunstan F DJ, Fehily A M, Breay P, Ashton T, Zotos P C, Haboubi N AA, Elwood P C. Lack of benefit of dietary advice to men with angina: results of a controlled trial. Eur J Clin Nutr. 2003; 57 193-200
- 4 De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J. et al . European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J. 2003; 24 1601-10
- 5 Harris W S, von Schacky C. The omega-3 index: A new risk factor for death from coronary heart disease?. Prev Med. 2004; 39 212-20
- 6 Hooper L, Thompson R L, Harrison R A, Summerbell C D, Ness A R, Moore H J, Worthington H V, Durrington P N, Higgins J P, Capps N E, Riemersma R A, Ebrahim S B, Smith G D. Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review. BMJ. 2006; 332 752-60
- 7 Marchioli R, Barzi F, Bomba E. et al . Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction. Time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarcto Miocardio (GISSI)-Prevenzione. Circulation. 2002; 105 1897-1903
- 8 Siscovick D S, Raghunathan T E, King I, Weinmann S, Wicklund K G, Albright J, Bovbjerg V, Arbogast P, Smith H, Kushi L H. et al . Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. J Am Med Assoc. 1995; 275 836-7
- 9 Smith S C, Allen J, Blair S N, Bonow R O, Brass L M, Fonarow G C. et al . AHA/ACC Guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update. Circulation. 2006; 113 2363-72
- 10 The GISSI Prevenzione Group . Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myo-cardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet. 1999; 354 447-55 Lancet. 2001; 357 642
- 11 von Schacky C. Prophylaxis of atherosclerosis with marine omega-3 fatty acids - a comprehensive strategy. Ann Int Med. 1987; 107 890-99
- 12 von Schacky C. Omega-3’s and cardiovascular disease. Curr Op Nutr Metab Care. 2004; 7 131-36
- 13 von Schacky C, Harris W S. Cardiovascular Risk and the omega-3 Index. DOI: 10.1016/j.cardiores.2006.08.019 Cardiovasc Res. 2006;
- 14 Wang C, Harris W S, Chung M, Lichtenstein A H, Balk E M, Kupelnick B, Jordan H S, Lau J. n-3 fatty acids from fish oil or fish oil supp-lements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review. Am J Clin Nutr. 2006; 84 5-17
- 15 Yokoyama M, Origasea H. for the JELIS Investigators . Effects of eicosapentaenoic acid on cardiovascular events in Japanese patients with hypercholesterolemia: Rationale, design, and baseline characteristics of the Japan EPA Lipid Intervention Study (JELIS). Am Heart J. 2003; 146 613-620
- 16 Zipes D P, Camm A J, Borggrefe M, Buxton A E, Chaiman B, Fromer M, Gregoratos G, Klein G, Moss A J, Myerburg R J, Priori S G, Quinones M A, Roden D M, Silka M J, Tracy C. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death - executive summary: a report of the American College of Cardio-logy/American Heart Association Task Force and the European Society for Cardio-logy Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventri-cular Arrhythmias and the Prevention of Sudden Cardiac Death). Eur Heart J. 2006; 27 2099-140
Prof. Dr. Clemens von Schacky
Ludwig-Maximilians-Universität München
Ziemssenstr. 1
80336 München
Email: Clemens.vonSchacky@med.uni-muenchen.de